LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 72.52 | 84.90 | 6158 | 9214 | 0.6683 | 0.8843 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 72.52 | 84.90 | 8563 | 9214 | 0.9293 | 0.9784 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 72.52 | 84.90 | 901 | 9214 | 0.0978 | 0.4181 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 72.52 | 84.90 | 9275 | 9214 | 1.0066 | 1.0019 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 72.52 | 84.90 | 873 | 9214 | 0.0947 | 0.4115 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 72.52 | 84.90 | 9782 | 9214 | 1.0616 | 1.0178 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 74.22 | 84.90 | 7291 | 9343 | 0.7803 | 0.9282 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 74.22 | 84.90 | 7583 | 9343 | 0.8116 | 0.9394 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 74.22 | 84.90 | 4085 | 9343 | 0.4372 | 0.7703 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 74.22 | 84.90 | 8634 | 9343 | 0.9241 | 0.9769 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 74.22 | 84.90 | 997 | 9343 | 0.1067 | 0.4379 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 74.22 | 84.90 | 9478 | 9343 | 1.0144 | 1.0042 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 74.22 | 84.90 | 784 | 9343 | 0.0839 | 0.3879 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 74.22 | 84.90 | 9996 | 9343 | 1.0698 | 1.0200 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 75.93 | 84.90 | 7270 | 8970 | 0.8104 | 0.9384 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 75.93 | 84.90 | 7660 | 8970 | 0.8539 | 0.9536 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 75.93 | 84.90 | 2964 | 8970 | 0.3304 | 0.6963 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 75.93 | 84.90 | 8651 | 8970 | 0.9644 | 0.9892 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 75.93 | 84.90 | 885 | 8970 | 0.0987 | 0.4172 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 75.93 | 84.90 | 9656 | 8970 | 1.0764 | 1.0220 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 75.93 | 84.90 | 817 | 8970 | 0.0911 | 0.4004 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 75.93 | 84.90 | 10194 | 8970 | 1.1364 | 1.0384 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 77.64 | 84.90 | 7080 | 9245 | 0.7658 | 0.9227 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 77.64 | 84.90 | 7654 | 9245 | 0.8279 | 0.9449 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 77.64 | 84.90 | 2638 | 9245 | 0.2853 | 0.6617 | MN20160318_Q02 | D05 |